These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6159973

  • 1. Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro.
    Hill BT, Whelan RD.
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():5-15. PubMed ID: 6159973
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
    Jordan MA, Himes RH, Wilson L.
    Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines.
    Photiou A, Sheikh MN, Bafaloukos D, Retsas S.
    J Cancer Res Clin Oncol; 1992 Jun; 118(4):249-54. PubMed ID: 1577845
    [Abstract] [Full Text] [Related]

  • 4. Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.
    Hill BT, Whelan RD.
    Cancer Chemother Pharmacol; 1982 Jun; 8(2):163-9. PubMed ID: 7105380
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
    Howard SM, Theologides A, Sheppard JR.
    Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.
    Evans BD, Smith IE, Shorthouse AJ, Millar JL.
    Br J Cancer; 1982 Mar; 45(3):466-8. PubMed ID: 6280742
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer.
    Nelson RL, Dyke RW, Root MA.
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():17-24. PubMed ID: 7438117
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of vinblastine, vincristine, and vindesine on neutrophil phagocytosis and iodination.
    Chohan V, Lowenthal RM.
    Cancer Treat Rep; 1982 Mar; 66(3):505-8. PubMed ID: 7037181
    [No Abstract] [Full Text] [Related]

  • 11. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
    Hill BT, Whelan RD.
    J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
    [Abstract] [Full Text] [Related]

  • 12. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E, Tarasiuk J, Garnier-Suillerot A.
    Chem Biol Interact; 1998 Jul 03; 114(1-2):61-76. PubMed ID: 9744556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).
    Dyke RW, Nelson RL.
    Cancer Treat Rev; 1977 Jun 03; 4(2):135-42. PubMed ID: 329987
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vindesine: a new vinca alkaloid.
    Bayssas M, Gouveia J, de Vassal F, Misset JL, Schwarzenberg L, Ribaud P, Musset M, Jasmin C, Hayat M, Mathé G.
    Recent Results Cancer Res; 1980 Jun 03; 74():91-7. PubMed ID: 7003662
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.